BRD2 and breast carcinoma: This study aims to develop a non-invasive preoperative prediction model for evaluating NAT sensitivity in breast cancer (BC) patients, with the goal of assisting clinicians in formulating personalized treatment plans to maximize therapeutic efficacy.